Skip to main content
Clinical Trials/NCT04697316
NCT04697316
Completed
Not Applicable

Transcranial Direct Current Stimulation (tDCS) as a Cognitive Functioning Enhancement Treatment for ADHD Patients Compared to Healthy Controls

Hebrew University of Jerusalem1 site in 1 country63 target enrollmentAugust 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Transcranial Direct Current Stimulation
Sponsor
Hebrew University of Jerusalem
Enrollment
63
Locations
1
Primary Endpoint
Navon task
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This study will examine the possible effects of tDCS (Transcranial Direct Current Stimulation) treatment to the left DLPFC on cognitive functions which were found to be deficient amongst ADHD patients. The study will include 100 subjects, 50 of whom diagnosed with ADHD. Subjects will complete the ASRS questionnaire to measure ADHD symptoms severity. Next, subjects will complete a series of cognitive tasks, after which they will receive either tDCS treatment or a sham treatment. Finally, subjects will repeat the cognitive tasks. Later that day, a telephonic follow up will take place. ADHD symptoms will be assessed again the next day.

Registry
clinicaltrials.gov
Start Date
August 1, 2021
End Date
June 1, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Noa Beiman

Principal Investigator

Hebrew University of Jerusalem

Eligibility Criteria

Inclusion Criteria

  • Participation criteria for healthy participants
  • Right hand dominance.
  • No psychiatric nor neural diagnosis.
  • Participants must be able to comprehend the study's procedure and sign an informed consent.
  • Participation criteria for ADHD diagnosed participants
  • ADHD diagnosis (according to DSM V).
  • Right hand dominance.
  • Participants must be able to comprehend the study's procedure and sign an informed consent.
  • Participants who regularly use Methylphenidate will be required to avoid the medication for 24 hours prior to study and 12 hours post study.

Exclusion Criteria

  • a. Other psychiatric diagnoses (additional to ADHD). b. Drug use (excluding Methylphenidate). c. Neurological disorders. d. Pacemaker, Insulin pump

Outcomes

Primary Outcomes

Navon task

Time Frame: through study completion, up to 1 hour after treatment

change in accuracy, shorter RT's

Stop-signal

Time Frame: through study completion, up to 1 hour after treatment

change in response inhibition: shorter SSRT

N-back

Time Frame: through study completion

change in working memory: increase in hit rate

Stroop

Time Frame: through study completion, up to 1 hour after treatment

change in interference control: smaller interference effect

Time Reproduction task

Time Frame: through study completion, up to 1 hour after treatment

change in time perception: increased accuracy

Continuous Performance Task

Time Frame: through study completion, up to 1 hour after treatment

change in continuous concentration: increase in accuracy

Study Sites (1)

Loading locations...

Similar Trials